Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Niusule expands Chinese distribution

This article was originally published in The Tan Sheet

Executive Summary

U.S. nutraceutical supplement manufacturer Niusule Biotech extends its distribution in China through an agreement with China Nepstar Chain Drugstore Ltd., the country's largest chain. As of Aug. 25, Nepstar will distribute Niusule's Gummy Bear supplement through its 55 stores in Hangzhou, and in the future will distribute the product through chain's network in Shanghai, Ninbo, Tianjing and Suzhou. Monrovia, Calif.-based Niusule previously distributed to 226 outlets in Zhejiang province, Shanghai and Beijing

You may also be interested in...



Global Initiative Orders 120 Million Abbott, SD Biosensor COVID-19 Rapid Antigen Tests

Tests will be priced at under $5 each for low- and middle-income countries.

Coronavirus Update: Pfizer Urged To Delay Vaccine Submission

A letter from more than 60 leading public health and medical ethics experts has been sent to Pfizer's CEO Albert Bourla.

Intense Month Of Virtual EU Medtech Regulatory Meetings Ahead

Online meetings are extremely popular now with spaces starting to sell out. Despite COVID-19, EU MDR and IVDR deadlines are still looming and the medtech sector is facing the biggest challenges in its history.

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel